INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,514,533 | +54.1% | 59,982 | +28.7% | 0.00% | – |
| Q2 2023 | $983,102 | +24.1% | 46,593 | +0.3% | 0.00% | – |
| Q1 2023 | $792,237 | +7.5% | 46,466 | +26.0% | 0.00% | – |
| Q4 2022 | $737,042 | -15.6% | 36,889 | -9.0% | 0.00% | – |
| Q3 2022 | $873,000 | +17.7% | 40,534 | +7.7% | 0.00% | – |
| Q2 2022 | $742,000 | -3.6% | 37,625 | +14.8% | 0.00% | – |
| Q1 2022 | $770,000 | -4.0% | 32,776 | +11.3% | 0.00% | – |
| Q4 2021 | $802,000 | +22.8% | 29,440 | +24.2% | 0.00% | – |
| Q3 2021 | $653,000 | +4.5% | 23,704 | +8.0% | 0.00% | – |
| Q2 2021 | $625,000 | -23.0% | 21,945 | -7.9% | 0.00% | -100.0% |
| Q1 2021 | $812,000 | +12.9% | 23,826 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $719,000 | +8.8% | 21,612 | +5.0% | 0.00% | 0.0% |
| Q3 2020 | $661,000 | +57.8% | 20,580 | +35.4% | 0.00% | – |
| Q2 2020 | $419,000 | +82.2% | 15,197 | +5.9% | 0.00% | – |
| Q1 2020 | $230,000 | – | 14,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |